FDA approved Ryoncil ® as the first and only therapy for pediatric patients 2 months and older, including adolescents and teenagers, with steroid-refractory acute graft versus host disease (SR-aGvHD), ...
Graphene is a material poised to revolutionise the electronics and semiconductor industries. Once a laboratory curiosity, it now faces the critical challenge ...